Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments Life Science Investing
MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy to Evaluate Prevention of Graft-Versus-Host Disease Life Science Investing
PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research Life Science Investing
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004 Life Science Investing
RenovoRx To Announce Promising New Clinical Data Using its TAMP Therapy Platform in an Abstract to be Presented at ASCO GI 2026 Life Science Investing
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome Life Science Investing
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay Life Science Investing
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes Life Science Investing
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital Life Science Investing
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan Life Science Investing
